Parallel Advisors, LLC Simulations Plus, Inc. Transaction History

Parallel Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 20, 2024	BUY	$34.96 - $43.94 $244 - $307	7 New	7 $0
Q4 2022 Feb 03, 2023	SELL	$36.55 - $51.15 $219 - $306	-6 Reduced 46.15%	7 $0
Q3 2022 Nov 10, 2022	SELL	$47.75 - $66.88 $4,393 - $6,152	-92 Reduced 87.62%	13 $1,000
Q2 2022 Aug 01, 2022	BUY	$40.55 - $51.76 $3,973 - $5,072	98 Added 1400.0%	105 $5,000
Q4 2021 Jan 20, 2022	SELL	$37.1 - $57.45 $3,635 - $5,630	-98 Reduced 93.33%	7 $0
Q3 2021 Nov 02, 2021	BUY	$38.45 - $55.66 $3,768 - $5,454	98 Added 1400.0%	105 $4,000
Q2 2021 Aug 06, 2021	SELL	$49.67 - $68.96 $546 - $758	-11 Reduced 61.11%	7 $0
Q1 2021 Apr 23, 2021	BUY	$60.06 - $89.52 $1,081 - $1,611	18 New	18 $1,000

170

15.5M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $697M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.